BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 11, 2016
View Archived Issues
Abeona Therapeutics enters collaboration for research on epidermolysis bullosa
Read More
Novo Nordisk offers overview of second quarter 2016
Read More
Omeros' MASP-3 inhibitor shows efficacy in PNH model
Read More
ANXA1 signaling as a novel therapeutic target for the resolution of immune dysfunction in HIV
Read More
FDA approves Heron Therapeutics' Sustol for chemotherapy-induced nausea and vomiting
Read More
PET-based platform to screen and evaluate potential nanoparticles for photothermal treatment
Read More
ZEB1-induced EMT contributes to early pathogenesis and metastatic potential in lung cancer
Read More
Phase II study of vTv Therapeutics' TTP-399 mets primary endpoint
Read More
Pfizer patents retinoid RORgamma t receptor antagonists and IL-17 production inhibitors
Read More
Jn Therapeutics develops JAK1 inhibitors
Read More
Otsuka Pharmaceutical profiles progress of second quarter 2016
Read More
Roche patent reveals anti-HBV agents
Read More
FDA grants priority review to deflazacort NDAs for DMD
Read More
BMS to reacquire rights to ASLAN-002
Read More
JDRF enters development and discovery collaboration with Pacific Diabetes Technologies
Read More
Selvita signs a medicinal chemistry collaboration with UCSF
Read More
New international collaborations to tackle antimicrobial resistance
Read More
AstraZeneca announces increased equity interest in Moderna Therapeutics
Read More
Genmab and Gilead Sciences enter DuoBody license agreement
Read More
Oncolytics Biotech reports further data from phase II study of Reolysin in NSCLC
Read More
FDA accepts Amphivena Therapeutics' IND for AMV-564
Read More
PharmaMar receives response on the CORAIL trial of PM-1183
Read More
ADDC announces third call for proposals in partnership with AstraZeneca
Read More
Protalix BioTherapeutics reports efficacy and safety data from phase I/II study of PRX-102
Read More
HHS awards funding to advance Hologic's Procleix Zika Virus Assay
Read More
MPC-300-IV shows dose-related improvements in phase II trial in biologic refractory RA
Read More